Insider Shareholders with Direct Ownership of Evofem Biosciences, Inc. (EVFM)
This section provides a comprehensive overview of the insiders with direct ownership of Evofem Biosciences, Inc. (EVFM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Evofem Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Justin J. File
Chief Financial Officer |
722,854 | 162,280 | 810,982 $8,109 | 7 |
Feb 18, 2022
Added 35.69%
|
|
Alexander A Fitzpatrick
General Counsel and Secretary |
544,090 | 162,120 | 516,422 $5,164 | 7 |
Feb 18, 2022
Added 36.75%
|
|
Russell Barrans
Chief Commercial Officer |
218,180 | 51,478 | 448,554 $4,485 | 4 |
Jul 08, 2021
Reduced 4.27%
|
|
Kelly Culwell
Chief Medical Officer |
200,000 | 42,061 | 273,390 $2,733 | 2 |
May 20, 2021
Reduced 13.33%
|
|
Saundra L Pelletier
Chief Executive Officer |
1,621,249 | 455,300 | 186,722 $1,867 | 9 |
Dec 31, 2022
Reduced 21.12%
|
|
Lisa Dale Rarick
Director |
5,000 | 0 | 10,250 $102 | 1 |
Jun 11, 2021
Added 32.79%
|
|
Anthony Stephen O'Brien
Director |
8,140 | 0 | 8,140 $81 | 1 |
Jun 14, 2021
Added 50.0%
|
|
Acacia Research Corp
> 10% Shareholder |
0 | 9,138,504 | 1,000 $10 | 1 |
Jun 04, 2020
Reduced 99.99%
|
|
Kim P. Kamdar
Director |
10,000 | 10 | 0 $0 | 2 |
Dec 21, 2023
Reduced 100.0%
|
|
Yan Zhang
CFO |
0 | 104 | 0 $0 | 1 |
Jan 12, 2024
Reduced 100.0%
|